Cargando…
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
BACKGROUND: Magnesium sulphate (MgSO(4)) is the only treatment approved for fetal neuroprotection. No information on its use is available in the absence of a national registry of neonatal practices. The objective of our study was to evaluate the use of MgSO(4) for fetal neuroprotection in French ter...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596870/ https://www.ncbi.nlm.nih.gov/pubmed/28903747 http://dx.doi.org/10.1186/s12884-017-1489-z |